Categories
Breakthrough in lymphatic cancer treatment

Celebrating his 71st birthday this year, Czech chemist Professor Antonin Holy will also be able to celebrate the launch of clinical testing of a drug to treat non-Hodgkins Read more …
Regular intake of NSAIDs reduces breast cancer risk
USA - Non-steroidal anti-inflammatory drugs (NSAIDs) could reduce the risk for breast cancer by 71%, according to recent studies published in the journal BMC Cancer. In colorectal Read more …
Breast cancer
Five years of therapy with the drug tamoxifen has become the norm for postmenopausal women with hormone-sensitive breast cancer. However, this has several adverse side effects, Read more …
A promising outlook for new gentle breast cancer therapies

Targeted medication and gentle surgical procedures are the pillars of modern breast cancer therapy, according to participants at this year’s German Congress of Senology. Read more …
Synchronising drug and gene therapies
Cancer can be tackled with a combination of drug and genetic therapies, so that the effectiveness of individual treatments are enhanced.
Read more …
Increasing the range of minimally invasive tumour therapy
Surgery is no longer the automatic choice to eradicate malignant tumours.
Read more …


.jpg&contenttype=jpeg)



